SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend]
SEC Accession No. 0001615774-16-006882
Filing Date
2016-08-19
Accepted
2016-08-19 15:54:34
Documents
4

Document Format Files

Seq Description Document Type Size
1 10-12G/A s103912_1012ga.htm 10-12G/A 1190949
2 EXHIBIT 10.19 s103912_ex10-19.htm EX-10.19 292919
3 EXHIBIT 10-20 s103912_ex10-20.htm EX-10.20 10007
4 EXHIBIT 10.21 s103912_ex10-21.htm EX-10.21 11525
  Complete submission text file 0001615774-16-006882.txt   1506394
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-12G/A | Act: 34 | File No.: 000-55506 | Film No.: 161843182
SIC: 2834 Pharmaceutical Preparations